MedPath

University of Liege

University of Liege logo
🇧🇪Belgium
Ownership
Private
Established
1817-01-01
Employees
5K
Market Cap
-
Website
http://www.ulg.ac.be

Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness

Phase 2
Completed
Conditions
Disorders of Consciousness
Minimally Conscious State
Vegetative State
Interventions
Device: Anodal tDCS
Device: sham tDCS
First Posted Date
2012-08-27
Last Posted Date
2014-06-09
Lead Sponsor
University of Liege
Target Recruit Count
55
Registration Number
NCT01673126
Locations
🇧🇪

University Hospital of Liège, Liège, Belgium

Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow

Not Applicable
Completed
Conditions
Non Traumatic Osteonecrosis of the Femoral Head (Hip)
Interventions
Procedure: core decompression of the femoral head
Procedure: core decompression with autologous bone marrow implantation
First Posted Date
2012-03-06
Last Posted Date
2012-03-06
Lead Sponsor
University of Liege
Target Recruit Count
50
Registration Number
NCT01544712
Locations
🇧🇪

University of Liège, Liège, Belgium

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

Phase 1
Terminated
Conditions
Crohn's Disease
Interventions
Biological: Mesenchymal Stem Cells (MSC)
First Posted Date
2012-02-28
Last Posted Date
2021-05-12
Lead Sponsor
University of Liege
Target Recruit Count
13
Registration Number
NCT01540292
Locations
🇧🇪

University Hospital Liège, Liège, Belgium

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

Phase 2
Active, not recruiting
Conditions
Graft-Versus-Host Disease
Hematological Malignancies
Interventions
First Posted Date
2011-09-05
Last Posted Date
2024-05-09
Lead Sponsor
University of Liege
Target Recruit Count
200
Registration Number
NCT01428973
Locations
🇧🇪

AZ VUB Jette, Brussels, Brussels Region Capital, Belgium

🇧🇪

Jolimont Hospital Haine Saint Paul, Haine St-Paul, Hainaut, Belgium

🇧🇪

Jules Bordet Institute, Brussels, Brabant, Belgium

and more 10 locations

Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting

Phase 2
Withdrawn
Conditions
Nonunion Fracture
Interventions
Other: Culture medium without MSC.
Biological: Mesenchymal Stem Cells
First Posted Date
2011-09-05
Last Posted Date
2021-05-12
Lead Sponsor
University of Liege
Registration Number
NCT01429012
Locations
🇧🇪

Liège University Hospital, Liège, Belgium

Mesenchymal Stem Cells After Renal or Liver Transplantation

Phase 1
Completed
Conditions
Liver Failure
Kidney Failure
Interventions
Biological: Mesenchymal Stem Cells
First Posted Date
2011-09-05
Last Posted Date
2022-06-14
Lead Sponsor
University of Liege
Target Recruit Count
40
Registration Number
NCT01429038
Locations
🇧🇪

University Hospital Liege, Liege, Belgium

MSC and HSC Coinfusion in Mismatched Minitransplants

Phase 2
Terminated
Conditions
Myelodysplastic Syndromes
Leukemia, Lymphocytic, Chronic
Lymphoma, Non-Hodgkin
Leukemia, Lymphoblastic, Acute
Leukemia, Myelocytic, Chronic
Myeloproliferative Disorders
Hodgkin's Disease
Multiple Myeloma
Leukemia, Myeloid, Acute
Interventions
Biological: Mesenchymal stem cells
Other: Isotonic solution
First Posted Date
2010-01-11
Last Posted Date
2021-09-08
Lead Sponsor
University of Liege
Target Recruit Count
39
Registration Number
NCT01045382
Locations
🇧🇪

Bordet Institute, Brussels, Belgium

🇧🇪

UZA, Edeghem, Antwerpen, Belgium

🇧🇪

AZ St-Jan, Brugge, Flanders West, Belgium

and more 7 locations

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

Phase 2
Completed
Conditions
Hematologic Malignancies
Interventions
Procedure: Unmanipulated PBSC after nonmyeloablative conditioning
Procedure: CD8-depleted PBSC after nonmyeloablative conditioning
First Posted Date
2008-06-09
Last Posted Date
2011-09-02
Lead Sponsor
University of Liege
Target Recruit Count
54
Registration Number
NCT00693927
Locations
🇧🇪

CHU Sart Tilman, Liege, Belgium

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Phase 2
Recruiting
Conditions
Graft-versus-host Disease
Poor Graft Function
Low Donor T-cell Chimerism
Interventions
Biological: Mesenchymal stem cells
First Posted Date
2008-01-29
Last Posted Date
2024-05-09
Lead Sponsor
University of Liege
Target Recruit Count
100
Registration Number
NCT00603330
Locations
🇧🇪

AZ St Jan, Brugge, West Flanders, Belgium

🇧🇪

AZ VUB Jette, Brussels, Brabant, Belgium

🇧🇪

AZ Gasthuisberg Leuven, Leuven, Flamish Brabant, Belgium

and more 9 locations

Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

Phase 2
Completed
Conditions
Hematological Malignancies
First Posted Date
2008-01-29
Last Posted Date
2022-01-26
Lead Sponsor
University of Liege
Target Recruit Count
107
Registration Number
NCT00603954
Locations
🇧🇪

UZ Gent, Gent, Flanders Oost, Belgium

🇧🇪

UZA Stuyvenberg, Antwerpen, Belgium

🇧🇪

UZA, Antwerpen, Belgium

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath